-
Estimating GFR in Kidney Transplant Recipients: Considerations for Selecting Equations. Kidney Int. (IF 14.8) Pub Date : 2024-09-09 Krishna A Agarwal,Ogechi M Adingwupu,Hocine Tighiouart,Shiyuan Miao,Marc Froissart,Michael Mauer,Wei Yang,Vicente Torres,Martin de Borst,Goran Klintmalm,Emilio D Poggio,Peter Rossing,Ruben Velez,Anders Grubb,Andrew D Rule,Kamran Shaffi,Ashtar Chami,Andrew S Levey,Lesley A Inker
-
Targeted gene therapy for rare genetic kidney diseases. Kidney Int. (IF 14.8) Pub Date : 2024-08-31 Veenita Khare,Stephanie Cherqui
Chronic kidney disease (CKD) is one of the leading causes of mortality worldwide because of kidney failure and the associated challenges of its treatment including dialysis and kidney transplantation. About one-third of CKD cases are linked to inherited monogenic factors, making them suitable for potential gene therapy interventions. However, the intricate anatomical structure of the kidney poses a
-
Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity. Kidney Int. (IF 14.8) Pub Date : 2024-08-31 Florian Grahammer,Bernhard Dumoulin,Ramila E Gulieva,Hui Wu,Yaoxian Xu,Nurgazy Sulaimanov,Frederic Arnold,Lukas Sandner,Tomke Cordts,Abhijeet Todkar,Pierre Moulin,Wilfried Reichardt,Victor G Puelles,Rafael Kramann,Benjamin S Freedman,Hauke Busch,Melanie Boerries,Gerd Walz,Tobias B Huber
Progression of cystic kidney disease has been linked to activation of the mTORC1 signaling pathway. Yet the utility of mTORC1 inhibitors to treat patients with polycystic kidney disease remains controversial despite promising preclinical data. To define the cell intrinsic role of mTORC1 for cyst development, the mTORC1 subunit gene Raptor was selectively inactivated in kidney tubular cells lacking
-
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease. Kidney Int. (IF 14.8) Pub Date : 2024-08-30 Viknesh Selvarajah,Darren Robertson,Lars Hansen,Lutz Jermutus,Kirsten Smith,Angela Coggi,José Sánchez,Yi-Ting Chang,Hongtao Yu,Joanna Parkinson,Anis Khan,H Sophia Chung,Sonja Hess,Richard Dumas,Tabbatha Duck,Simran Jolly,Tom G Elliott,John Baker,Albert Lecube,Karl-Michael Derwahl,Russell Scott,Cristobal Morales,Carl Peters,Ronald Goldenberg,Victoria E R Parker,Hiddo J L Heerspink,
Cotadutide is a glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist that may improve kidney function in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). In this phase 2b study, patients with T2D and CKD ,estimated glomerular filtration rate [eGFR] of 20 or more and under 90 mL/min per 1.73 m2 and urinary albumin-to-creatinine ratio [UACR] over 50 mg/g) were randomized
-
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope. Kidney Int. (IF 14.8) Pub Date : 2024-08-30 Satoshi Miyamoto,Hiddo J L Heerspink,Dick de Zeeuw,Kota Sakamoto,Michihiro Yoshida,Masao Toyoda,Daisuke Suzuki,Takashi Hatanaka,Tohru Nakamura,Shinji Kamei,Satoshi Murao,Kazuyuki Hida,Shinichiro Ando,Hiroaki Akai,Yasushi Takahashi,Munehiro Kitada,Hisashi Sugano,Tomokazu Nunoue,Akihiko Nakamura,Motofumi Sasaki,Tatsuaki Nakatou,Kei Fujimoto,Daiji Kawanami,Takashi Wada,Nobuyuki Miyatake,Hiromi Kuramoto
Demonstrating drug efficacy in slowing kidney disease progression requires large clinical trials when targeting participants with an early stage of chronic kidney disease (CKD). In this randomized, parallel-group, open-labeled trial (CANPIONE study), we assessed the effect of the sodium-glucose cotransporter 2 (SGLT2) inhibitor canagliflozin using the individual's change in estimated glomerular filtration
-
Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease. Kidney Int. (IF 14.8) Pub Date : 2024-08-29 Audrey Dumont,Mouad Hamzaoui,Déborah Groussard,Michèle Iacob,Dominique Bertrand,Isabelle Remy-Jouet,Mélanie Hanoy,Frank Le Roy,Laurence Chevalier,Christoph Enzensperger,Hans-Dieter Arndt,Sylvanie Renet,Anaïs Dumesnil,Emilie Lévêque,Thomas Duflot,Valéry Brunel,Aurore Michel-Després,Marie-Pierre Audrézet,Vincent Richard,Robinson Joannidès,Dominique Guerrot,Jérémy Bellien
Altered polycystin-mediated endothelial flow mechanosensitivity contributes to the development of hypertension and cardiovascular complications in patients with autosomal dominant polycystic kidney disease (ADPKD). Stimulation of endothelial type 5 dopamine receptors (DR5) can acutely compensate for the endothelial consequences of polycystin deficiency, but the chronic impact of this approach must
-
Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuli. Kidney Int. (IF 14.8) Pub Date : 2024-08-29 Peiqi Hu,Hong Xiao,Marco A Alba,Hannah M Atkins,Shenju Gou,Yanglin Hu,John C Gomez,Corey M Jania,Jessica R Martin,Thomas E Morrison,Stephen L Tilley,Mark T Heise,Claire M Doerschuk,Ronald J Falk,J Charles Jennette
Anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis has diverse patterns of injury including microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Necrotizing and crescentic glomerulonephritis (NCGN) occurs in all syndromes and as renal limited vasculitis (RLV). Single dose intravenous ANCA IgG-specific for mouse myeloperoxidase
-
Nitrofurantoin-associated crystalline and granulomatous interstitial nephritis. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Samih H Nasr,Samar M Said,Allen Flickinger
-
The Case | Obstructive acute renal failure due to acute uric acid nephrolithiasis. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Antoine Decaestecker,Amandine Ydee,Camille Metzger,Arnaud Lionet,Sarah Barbieux,Timothée Laboux,Marie-Sophie Pagniez
-
Discrepancies between transcutaneous and estimated glomerular filtration rates in rats. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Daniel Schock-Kusch,Sabine Neudecker
-
Unveiling glomerular gold in oxalate nephropathy. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Jean-Baptiste Gibier,Ellie Tang,Dominique Bazin,Kadda Medjoubi,Andrea Somogyi,Michel Daudon,Laurence Vrigneaud,Emmanuel Letavernier
-
The significance of subclassifying focal segmental glomerulosclerosis lesions (S1) in IgA nephropathy. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Zhenjie Chen,Xuewang Li,Chao Li,Jianfang Cai,Hang Li
-
Kidney-limited TMA is common in patients with complement dysregulation. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Daan P C van Doorn,Pieter van Paassen,Sjoerd A M E G Timmermans,
-
Cardiovascular disease as a risk factor for frailty in dialysis patients. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Kah Cheong Tong,Khui Wei Wee
-
Aging kidneys reveal underlying mechanisms of endothelial dysfunction. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Ubong S Ekperikpe,Ilse S Daehn
Jiang et al. show that zinc finger FYVE-type containing 21, a Rab5 effector in glomerular endothelial cells is involved in the maintenance of glomerular filtration barrier homeostasis through the stabilization of activated endothelial nitric oxide synthase on subcellular vesicles. The study demonstrates that zinc finger FYVE-type containing 21 could modulate the levels of caveolin-1 in glomerular endothelial
-
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Carla M Nester,David L Feldman,Richard Burwick,Spero Cataland,Shruti Chaturvedi,H Terence Cook,Adam Cuker,Bradley P Dixon,Fadi Fakhouri,Sangeeta R Hingorani,Anuja Java,Nicole C A J van de Kar,David Kavanagh,Nelson Leung,Christoph Licht,Marina Noris,Michelle M O'Shaughnessy,Samir V Parikh,Flora Peyandi,Giuseppe Remuzzi,Richard J H Smith,C John Sperati,Meryl Waldman,Patrick Walker,Marina Vivarelli
The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed to the epidemic, typical form of the disease. Over time, the atypical hemolytic uremic syndrome term has evolved into being used to refer to anything that is not Shiga toxin-associated hemolytic uremic syndrome. The
-
Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Amit X Garg,Ann Young
Identifying people at risk for progressive chronic kidney disease and connecting them with recommended care is crucial for providing timely and optimal treatment. The ASSIST-CKD (A programme to Spread eGFR [estimated glomerular filtration rate] graph Surveillance for the early identification, Support and Treatment of people with progressive CKD [chronic kidney disease]) trial evaluated the effect of
-
The adaptive and innate immune systems coordinate for successful control of CMV infection. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Joanna M Schaenman
Previous studies of the immune control of cytomegalovirus infection have primarily focused on analysis of the traditional adaptive T-cell response. Donadeu et al. bring a new perspective through evaluation of multiple adaptive and innate immune subtypes in parallel with cytomegalovirus-specific cell-mediated immunity in a prospective cohort of kidney transplant recipients with findings validated in
-
See the power in kidney cells with ATP biosensor. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 János Peti-Peterdi,Georgina Gyarmati
Yamamoto et al. developed an exciting technical advance to examine intracellular adenosine triphosphate levels with single-cell resolution in intact living kidney tissue, including in tubular and vascular segments that lie deep under the kidney surface. The work is a significant advance on prior in vivo biosensor studies, and it allows for mechanistic investigation of alterations in cell metabolism
-
Chemical chaperones to the rescue of Alport syndrome? Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Roberto M Vanacore
Alport syndrome is a hereditary kidney disease caused by collagen IV mutations that interfere with the formation and deposition of the α3α4α5 protomer into the glomerular basement membrane. In this issue, Yu et al. show that the chemical chaperone tauroursodeoxycholic acid prevented kidney structural changes and function decline in mice with a pathogenic missense Col4a3 mutation by increasing mutant
-
Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Phoom Narongkiatikhun,Petter Bjornstad
The attenuation of glomerular hyperfiltration is posited to be a principal mechanism underlying the kidney protective effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors in diabetic kidney disease. Notably, the impact of SGLT2 inhibitors on kidney hemodynamic function has been posited to vary between type 1 and type 2 diabetes. The study by Wada et al. documents that in an animal model of
-
The unfairness of fairness creams: unveiling the toxic impact on kidneys of mercury in beauty products. Kidney Int. (IF 14.8) Pub Date : 2024-09-01 Priti Meena,Vivekanand Jha
-
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN). Kidney Int. (IF 14.8) Pub Date : 2024-08-27 Valentin Goutaudier,Richard Danger,Rusan Ali Catar,Maud Racapé,Aurélie Philippe,Michelle Elias,Marc Raynaud,Olivier Aubert,Didier Bouton,François Girardin,Éric Vicaut,Sarhan Yaiche,Jacques Demotes,Harald Heidecke,Jean-Luc Taupin,Christine Randoux-Lebrun,Mohamad Zaidan,Emmanuelle Papuchon,Hoa Le Mai,Thi-Van-Ha Nguyen,Francesc Moreso,Thierry Berney,Jean Villard,Christophe Legendre,Duska Dragun,Vassilios
Non-invasive biomarkers are promising tools for improving kidney allograft rejection monitoring, but their clinical adoption requires more evidence in specifically designed studies. To address this unmet need, we designed the EU-TRAIN study, a large prospective multicentric unselected cohort funded by the European Commission. Here, we included consecutive adult patients who received a kidney allograft
-
A reliable clinical test for detection of membranous nephropathy antigens using laser microdissection and mass spectrometry. Kidney Int. (IF 14.8) Pub Date : 2024-08-26 Julie A Vrana,Jason D Theis,Peter J Wegwerth,Surendra Dasari,Benjamin Madden,Samih H Nasr,Mary Fidler,Ellen D McPhail,Fernando C Fervenza,Sanjeev Sethi
Membranous nephropathy (MN) results from accumulation of antigen-antibody immune complexes along the subepithelial region of the glomerular basement membranes. Over the last years, 13 target antigens have been discovered and include PLA2R, THSD7A, EXT1 and EXT2, NELL1, SEMA3B, NCAM1, CNTN1, HTRA1, FAT1, PCDH7, NTNG1, PCSK6 and NDNF, accounting for 80-90% of MN antigens. MN associated with many of these
-
Hair-straightening cosmetics containing glyoxylic acid induce crystalline nephropathy. Kidney Int. (IF 14.8) Pub Date : 2024-08-26 Thomas Robert,Ellie Tang,Jennifer Kervadec,Aurore Desmons,Jean-Yves Hautem,Jeremy Zaworski,Michel Daudon,Emmanuel Letavernier
We recently reported the case of a patient who experienced three consecutive episodes of acute kidney injury, all of them following a "Brazilian" hair-straightening treatment. The cream used for the straightening procedure contained glyoxylic acid. To examine possible underlying mechanisms causing kidney injury, four groups of mice were exposed to topical application of (i) the straightening product
-
Targeting APRIL in the treatment of glomerular diseases. Kidney Int. (IF 14.8) Pub Date : 2024-08-23 Chee Kay Cheung,Jonathan Barratt,Richard Lafayette,Adrian Liew,Yusuke Suzuki,Vladimír Tesař,Hernán Trimarchi,Muh Geot Wong,Hong Zhang,Dana V Rizk
A PRoliferation Inducing Ligand (APRIL) is a key member of the tumor necrosis factor (TNF)-superfamily of cytokines, and plays a central role in B cell survival, proliferation and immunoglobulin class switching. Recently, there has been increasing interest in the role of APRIL and the related cytokine B cell activating factor (BAFF) in several glomerular diseases, due to their importance in the above
-
Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2. Kidney Int. (IF 14.8) Pub Date : 2024-08-23 Esilida Sula Karreci,Sonako Jacas,Olivia Donovan,Diana Pintye,Nicholas Wiley,Zsuzsanna K Zsengeller,Johannes Schlondorff,Seth L Alper,David J Friedman,Martin R Pollak
Apolipoprotein L1 (APOL1) variants G1 and G2 contribute to the excess risk of kidney disease in individuals of recent African ancestry. Since disease mechanisms and optimal treatments remain controversial, we study the effect of current standard-of-care drugs in mouse models of APOL1 kidney disease. Experiments were performed in APOL1 BAC-transgenic mice, which develop proteinuria and glomerulosclerosis
-
Stronger together: the power of cross-organ data sets for improved allograft study outcomes Kidney Int. (IF 14.8) Pub Date : 2024-08-22 Thibaut Vaulet, Maarten Naesens
-
FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection. Kidney Int. (IF 14.8) Pub Date : 2024-08-22 Sanjeev Sethi,Benjamin Madden,Marta Casal Moura,Samih H Nasr,Mariam P Alexander,Hanna Debiec,Nate Torrel,LouAnn Gross,Vivian Negron,Ulrich Specks,Fernando C Fervenza,Mark Haas,Pierre Ronco,Ibrahim Batal
-
Transcription factor Twist1 drives fibroblast activation to promote kidney fibrosis via signaling proteins Prrx1/TNC3 Kidney Int. (IF 14.8) Pub Date : 2024-08-22 Lianqin Sun, Lishan Liu, Juanjuan Jiang, Kang Liu, Jingfeng Zhu, Lin Wu, Xiaohan Lu, Zhimin Huang, Yanggang Yuan, Steven D. Crowley, Huijuan Mao, Changying Xing, Jiafa Ren
The transcription factor Twist1 plays a vital role in normal development in many tissue systems and continues to be important throughout life. However, inappropriate Twist1 activity has been associated with kidney injury and fibrosis, though the underlying mechanisms involved remain incomplete. Here, we explored the role of Twist1 in regulating fibroblast behaviors and the development kidney fibrosis
-
Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients Kidney Int. (IF 14.8) Pub Date : 2024-08-22 Michelle Willicombe, David J. Roberts
Human leukocyte antigen (HLA) sensitization remains an impediment to successful solid organ transplantation, whether it be chances of receiving a transplant offer or subsequent transplant longevity. Current treatments targeting HLA antibodies lack long-term effectiveness; therefore, preventing HLA sensitization should remain a priority in all potential wait-list candidates and transplant recipients
-
In memoriam: George L. Bakris, MD, 1952–2024 Kidney Int. (IF 14.8) Pub Date : 2024-08-14 Arlene B. Chapman, Mohammad A. Rafey, Glenn M. Chertow, Matthew Weir
-
Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study Kidney Int. (IF 14.8) Pub Date : 2024-08-13 Keila Turino Miranda, Sandra M. Dumanski, Nathalie Saad, Lesley A. Inker, Christine A. White, Pierre Delanaye, David Collister, Dina N. Greene, Cameron T. Whitley, Tyrone G. Harrison, Chantal L. Rytz, Lindsay Peace, Darlene Y. Sola, Sofia B. Ahmed
[Display omitted]
-
Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism–related vascular thrombosis with microvascular injury and its consequences Kidney Int. (IF 14.8) Pub Date : 2024-08-12 Danyang Zhao, Chao Han, Elmina Mammadova-Bach, Kanako Watanabe-Kusunoki, Tamisa Seeko Bandeira Honda, Yihong Li, Chenyu Li, Qiubo Li, Hao Long, Lyuben Lyubenov, Chongxu Shi, Donato Santovito, Christian Weber, Peter Boor, Patrick Droste, Samir Parikh, John Shapiro, Letizia De Chiara, Giulia Carangelo, Paola Romagnani, Sven Klussmann, Axel Vater, Hans-Joachim Anders
Cholesterol crystal embolism (CCE) implies immunothrombosis, tissue necrosis, and organ failure but no specific treatments are available. As CCE involves complement activation, we speculated that inhibitors of the C5a/C5aR axis would be sufficient to attenuate the consequences of CCE like that with systemic vasculitis. Cholesterol microcrystal injection into the kidney artery of wild-type mice initiated
-
Individual and neighborhood-level social and deprivation factors impact kidney health in the GLOMMS-CORE study Kidney Int. (IF 14.8) Pub Date : 2024-08-12 Simon Sawhney, Iain Atherton, Thomas Blakeman, Corri Black, Eilidh Cowan, Catherine Croucher, Simon D.S. Fraser, Audrey Hughes, Mintu Nath, Dorothea Nitsch, Nicole Scholes-Robertson, Magdalena Rzewuska Diaz
Prospective cohort studies of kidney equity are limited by a focus on advanced rather than early disease and selective recruitment. Whole population studies frequently rely on area-level measures of deprivation as opposed to individual measures of social disadvantage. Here, we linked kidney health and individual census records in the North of Scotland (Grampian area), 2011-2021 (GLOMMS-CORE) and identified
-
Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft Kidney Int. (IF 14.8) Pub Date : 2024-08-09 Ibrahim Batal, Andrew J.B. Watts, Jean-Baptiste Gibier, Aghiles Hamroun, Isabelle Top, François Provot, Keith Keller, Xiaoyi Ye, Hilda E. Fernandez, Rita Leal, Nicole K. Andeen, Russell J. Crew, Geoffrey K. Dube, Elena-Rodica Vasilescu, Lloyd E. Ratner, Nicole Bowman, Andrew S. Bomback, Simone Sanna-Cherchi, Krzysztof Kiryluk, Astrid Weins
[Display omitted]
-
Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium Kidney Int. (IF 14.8) Pub Date : 2024-08-07 Natalie Ebert, Elke Schaeffner, Jesse C. Seegmiller, Marco van Londen, Arend Bökenkamp, Etienne Cavalier, Pierre Delanaye, Laurence Derain-Dubourg, Bjørn O. Eriksen, Olafur S. Indridason, Runolfur Palsson, Tariq Shafi, Anders Christensson, Sebastjan Bevc, Fabiola Carrara, Marie Courbebaisse, R. Neil Dalton, Markus van der Giet, Toralf Melsom, Shona Methven, Gunnar Nordin, Hans Pottel, Andrew D. Rule
International consensus supports the development of standardized protocols for measured glomerular filtration rate (mGFR) to facilitate the integration of mGFR testing in both clinical and research settings. To this end, the European Kidney Function Consortium convened an international group of experts with relevant experience in mGFR. The working group performed an extensive literature search to inform
-
Dynamically visualizing profibrotic maladaptive repair after acute kidney injury by fibroblast activation protein imaging Kidney Int. (IF 14.8) Pub Date : 2024-08-03 Jiawen Huang, Shuang Cui, Xiaohua Chi, Ansheng Cong, Xiaoqiang Yang, Huanjuan Su, Zhanmei Zhou, Cailing Su, Zuoyu Hu, Zhijie Huang, Jiao Luo, Guobao Wang, Ying Jiang, Ganghua Tang, Wei Cao
A major challenge in prevention and early treatment of organ fibrosis is the lack of valuable tools to assess the evolving profibrotic maladaptive repair after injury in a non-invasive way. Here, using acute kidney injury (AKI) as an example, we tested the utility of fibroblast activation protein (FAP) imaging for dynamic assessment of maladaptive repair after injury. The temporospatial pattern of
-
The Case | Asymmetric kidney cysts in a patient with negative family history. Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Othmane Mohib,Suzanne Vanhauwaert,Lisanne De Boeck,Kathleen B M Claes,Peter Janssens
-
Unusual cause of retroperitoneal leak in a patient undergoing peritoneal dialysis. Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Nicolas A D Bergeron,Alexandre Candellier,Mathieu Rousseau-Gagnon,Fabrice Mac-Way
-
Normalizing serum phosphate based on association, not causation? Lessons in dialysis should have taught us not to fix what we can't prove is broken. Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Nigel D Toussaint,Sunil V Badve
-
Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis. Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Takayuki Hamano,Masafumi Fukagawa
-
DNA-binding protein-A: a multitool in tubular epithelial cells. Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Patrick Droste,Peter Boor,Roman D Bülow
Acute kidney injury is still associated with high morbidity and mortality. Reichardt et al. investigated DNA-binding protein-A (Ybx3) in acute kidney injury induced by ischemia-reperfusion injury and found that mice lacking Ybx3 have altered mitochondrial function and increased antioxidant activity, making them more resistant to ischemia-reperfusion injury-acute kidney injury. The study highlights
-
Any reduction in maternal kidney mass associated with adverse pregnancy outcomes: more evidence is needed. Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Shiyuan Wei,Qi Gao,Yanqin Li,Licong Su
-
Reducing serum phosphate level: how low should we go? Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Tilman B Drüeke
-
Acute kidney injury genetic risks: taking it 1 SNP at a time. Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Jonathan Himmelfarb,Ian B Stanaway,Pavan K Bhatraju
This commentary addresses some of the strengths, shortcomings, and challenges of the genome-wide association study of acute kidney injury (AKI) report in this issue. This AKI genome-wide association study is well executed and provides significant progress in finding 2 genome-wide significant loci. However, significant interpretive challenges remain, where advancements in methods are needed because
-
Lactate: a missing link between metabolism and inflammation in CKD progression? Kidney Int. (IF 14.8) Pub Date : 2024-08-01 Nobuaki Nishima,Shinji Tanaka
Persistent enhancement of glycolysis in kidney tubular epithelial cells has been linked to the progression of chronic kidney disease, although the underlying mechanisms are largely unknown. In this issue of Kidney International, Wang et al. report that the glycolytic enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 plays a crucial role in kidney fibrosis by enhancing histone H4 lysine
-
Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy Kidney Int. (IF 14.8) Pub Date : 2024-07-31 Sean J. Barbour, Rosanna Coppo, Lee Er, Maria Luisa Russo, Zhi-Hong Liu, Jie Ding, Xuhui Zhong, Ritsuko Katafuchi, Norishige Yoshikawa, Hong Xu, Shoji Kagami, Yukio Yuzawa, Francesco Emma, Alexandra Cambier, Licia Peruzzi, Robert J. Wyatt, Daniel C. Cattran, International IgA Nephropathy Network Research Group, Caihong Zeng MD, Biage Su MD, Xuhui Zhong MD, Koichi Nakanishi MD, Yihui Zhai MD, Maki Urushihara
The pediatric International IgA Nephropathy (IgAN) Prediction Tool comprises two models with and without ethnicity and is the first method to predict the risk of a 30% decline in estimated glomerular filtration rate (eGFR) or kidney failure in children at the time of biopsy using clinical risk factors and Oxford MEST histology scores. However, it is unknown if the Prediction Tool can be applied after
-
Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain Kidney Int. (IF 14.8) Pub Date : 2024-07-30 Silke Zimmermann, Akash Mathew, Olga Bondareva, Ahmed Elwakiel, Klarina Waldmann, Shihai Jiang, Rajiv Rana, Kunal Singh, Shrey Kohli, Khurrum Shahzad, Ronald Biemann, Thomas Roskoden, Silke Diana Storsberg, Christian Mawrin, Ute Krügel, Ingo Bechmann, Jürgen Goldschmidt, Bilal N. Sheikh, Berend Isermann
Cognitive impairment is common in extracerebral diseases such as chronic kidney disease (CKD). Kidney transplantation reverses cognitive impairment, indicating that cognitive impairment driven by CKD is therapeutically amendable. However, we lack mechanistic insights allowing development of targeted therapies. Using a combination of mouse models (including mice with neuron-specific IL-1R1 deficiency)
-
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration Kidney Int. (IF 14.8) Pub Date : 2024-07-30 Matthias Rose, Felix H. Fischer, Gregor Liegl, Giovanni F.M. Strippoli, Carina Hockham, Robin W.M. Vernooij, Claudia Barth, Bernard Canaud, Adrian Covic, Krister Cromm, Andrea M. Cucui, Andrew Davenport, Kathrin I. Fischer, Jörgen Hegbrant, Hanna Jaha, Anna Schappert, Marietta Török, Mark Woodward, Michiel L. Bots, Peter J. Blankestijn, CONVINCE Scientific Committee and CONVINCE Investigators
In the CONVINCE trial, the primary analysis demonstrated a survival benefit for patients receiving high-dose hemodiafiltration (HDF) as compared with high-flux hemodialysis (HD). A secondary objective was to evaluate effects on health-related quality of life (HRQoL); assessed in eight domains (physical function, cognitive function, fatigue, sleep disturbance, anxiety, depression, pain interference
-
Genetic deletion of the kidney sodium/proton exchanger-3 (NHE3) does not alter calcium and phosphate balance due to compensatory responses Kidney Int. (IF 14.8) Pub Date : 2024-07-30 Søren B. Poulsen, Sathish K. Murali, Linto Thomas, Adrienne Assmus, Lena L. Rosenbæk, Rikke Nielsen, Henrik Dimke, Timo Rieg, Robert A. Fenton
The sodium/proton exchanger-3 (NHE3) plays a major role in acid–base and extracellular volume regulation and is also implicated in calcium homeostasis. As calcium and phosphate balances are closely linked, we hypothesized that there was a functional link between kidney NHE3 activity, calcium, and phosphate balance. Therefore, we examined calcium and phosphate homeostasis in kidney tubule–specific NHE3
-
Augmentative effects of leukemia inhibitory factor reveal a critical role for TYK2 signaling in vascular calcification Kidney Int. (IF 14.8) Pub Date : 2024-07-30 Ioana Alesutan, Mehdi Razazian, Trang T.D. Luong, Misael Estepa, Lakmi Pitigala, Laura A. Henze, Jakob Obereigner, Gregor Mitter, Daniel Zickler, Mirjam Schuchardt, Christine Deisl, Manousos Makridakis, Can Gollmann-Tepeköylü, Andreas Pasch, Daniel Cejka, Susanne Suessner, Marlies Antlanger, Bernhard Bielesz, Mathias Müller, Antonia Vlahou, Johannes Holfeld, Kai-Uwe Eckardt, Jakob Voelkl
Medial vascular calcification in chronic kidney disease (CKD) involves pro-inflammatory pathways induced by hyperphosphatemia. Several interleukin 6 family members have been associated with pro-calcific effects in vascular smooth muscle cells (VSMCs) and are considered as therapeutic targets. Therefore, we investigated the role of leukemia inhibitory factor (LIF) during VSMC calcification. LIF expression
-
The mechanosensitive ion channel Piezo1 contributes to podocyte cytoskeleton remodeling and development of proteinuria in lupus nephritis Kidney Int. (IF 14.8) Pub Date : 2024-07-29 Rong Fu, Wenqian Wang, Yongbao Huo, Liu Li, Ruilin Chen, Zeying Lin, Yi Tao, Xuan Peng, Wenhui Huang, Chaohuan Guo
Piezo1 functions as a special transducer of mechanostress into electrochemical signals and is implicated in the pathogenesis of various diseases across different disciplines. However, whether Piezo1 contributes to the pathogenesis of lupus nephritis (LN) remains elusive. To study this, we applied an agonist and antagonist of Piezo1 to treat lupus-prone MRL/lpr mice. Additionally, a podocyte-specific
-
Population-based reference values for kidney function and kidney function decline in 25- to 95-year-old Germans without and with diabetes Kidney Int. (IF 14.8) Pub Date : 2024-07-29 Janina M. Herold, Simon Wiegrebe, Jana Nano, Bettina Jung, Mathias Gorski, Barbara Thorand, Wolfgang Koenig, Tanja Zeller, Martina E. Zimmermann, Ralph Burkhardt, Bernhard Banas, Helmut Küchenhoff, Klaus J. Stark, Annette Peters, Carsten A. Böger, Iris M. Heid
Understanding normal aging of kidney function is pivotal to help distinguish individuals at particular risk for chronic kidney disease. Glomerular filtration rate (GFR) is typically estimated via serum creatinine (eGFRcrea) or cystatin C (eGFRcys). Since population-based age-group-specific reference values for eGFR and eGFR-decline are scarce, we aimed to provide such reference values from population-based
-
Galectin-3 contributes to pathogenesis of IgA nephropathy Kidney Int. (IF 14.8) Pub Date : 2024-07-29 Yu-Ling Chou, Hung-Lin Chen, Bang-Gee Hsu, Chih-Yu Yang, Cheng-Hsu Chen, Yu-Ching Lee, I-Lin Tsai, Chih-Chien Sung, Chia-Chao Wu, Shin-Ruen Yang, Yusuke Suzuki, Edwin Yates, Kuo-Feng Hua, Lu-Gang Yu, Fu-Tong Liu, Ann Chen, Shuk-Man Ka
IgA nephropathy (IgAN) is the most common type of glomerulonephritis that frequently progresses to kidney failure. However, the molecular pathogenesis underlying IgAN remains largely unknown. Here, we investigated the role of galectin-3 (Gal-3), a galactoside-binding protein in IgAN pathogenesis, and showed that Gal-3 expression by the kidney was significantly enhanced in patients with IgAN. In both
-
The membrane transporter SLC25A48 enables transport of choline into human mitochondria Kidney Int. (IF 14.8) Pub Date : 2024-07-29 Suraj Patil, Oleg Borisov, Nora Scherer, Christophe Wirth, Pascal Schlosser, Matthias Wuttke, Sandra Ehret, Luciana Hannibal, Kai-Uwe Eckardt, Carola Hunte, Björn Neubauer, Anna Köttgen, Michael Köttgen
Choline has important physiological functions as a precursor for essential cell components, signaling molecules, phospholipids, and the neurotransmitter acetylcholine. Choline is a water-soluble charged molecule requiring transport proteins to cross biological membranes. Although transporters continue to be identified, membrane transport of choline is incompletely understood and knowledge about choline
-
Pseudogene GSTM3P1 derived long non-coding RNA promotes ischemic acute kidney injury by target directed microRNA degradation of kidney-protective mir-668 Kidney Int. (IF 14.8) Pub Date : 2024-07-27 Qingqing Wei, Jing Huang, Man Jiang Livingston, Shixuan Wang, Guie Dong, Hongyan Xu, Jiliang Zhou, Zheng Dong
Long non-coding RNAs (lncRNAs) are a group of epigenetic regulators that have been implicated in kidney diseases including acute kidney injury (AKI). However, very little is known about the specific lncRNAs involved in AKI and the mechanisms underlying their pathologic roles. Here, we report a new lncRNA derived from the pseudogene , which mediates ischemic AKI by interacting with and promoting the
-
Deceased donor kidney function and branched chain amino acid metabolism during ex vivo normothermic perfusion Kidney Int. (IF 14.8) Pub Date : 2024-07-27 Armin Ahmadi, Jacquelyn Yu, Jennifer E. Loza, Brian C. Howard, Ivonne Palma, Naeem Goussous, Junichiro Sageshima, Baback Roshanravan, Richard V. Perez
Current kidney perfusion protocols are not optimized for addressing the physiological and metabolic needs of the kidney. normothermic perfusion may be utilized to distinguish high-risk kidneys to determine suitability for transplantation. Here, we assessed the association of tissue metabolic changes with changes in a kidney injury biomarker and functional parameters in eight deceased donor kidneys
-
Nanotherapeutic kidney cell-specific targeting to ameliorate acute kidney injury Kidney Int. (IF 14.8) Pub Date : 2024-07-25 Yoshio Funahashi, Seung Hun Park, Jessica F. Hebert, Mahaba B. Eiwaz, Adam C. Munhall, Tahnee Groat, Lingxue Zeng, Jonghan Kim, Hak Soo Choi, Michael P. Hutchens
Acute kidney injury (AKI) increases the risk of in-hospital death, adds to expense of care, and risk of early chronic kidney disease. AKI often follows an acute event such that timely treatment could ameliorate AKI and potentially reduce the risk of additional disease. Despite therapeutic success of dexamethasone in animal models, clinical trials have not demonstrated broad success. To improve the
-
Podocyte density as a predictor of long-term kidney outcome in obesity-related glomerulopathy Kidney Int. (IF 14.8) Pub Date : 2024-07-24 Kotaro Haruhara, Yusuke Okabayashi, Takaya Sasaki, Eisuke Kubo, Vivette D. D'Agati, John F. Bertram, Nobuo Tsuboi, Takashi Yokoo
Glomerulomegaly and focal segmental glomerulosclerosis are histopathological hallmarks of obesity-related glomerulopathy (ORG). Podocyte injury and subsequent depletion are regarded as key processes in the development of these glomerular lesions in patients with ORG, but their impact on long-term kidney outcome is undetermined. Here, we correlated clinicopathological findings and podocyte depletion